Deutsche Bank has a Buy rating and a $78 price target on shares of Thermo Fisher Scientific Inc. TMO.
In a note to clients, Deutsche Bank writes, "We estimate TMO should trade at 17.5-19.5x our $4.20 FY11 EPS estimate and 14-16x our $5.25 FY12 EPS estimate (including FAS-123 expenses). These multiples, which are in line with the sector, imply an equity value per share, based on our FY11 and FY12 P/E assumptions, of $73.59-$81.98 and $73.18-$83.67, respectively."
Shares of TMO lost 79 cents yesterday to close at $64.78, a loss of 1.2%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsDeutsche BankHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in